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We investigated whether multilocus variable-number tandem-repeat analysis (MLVA) typing could identify
different subtypes of Clostridium difficile ribotype 027 within the same feces specimen. Five of 39 specimens
yielded at least one isolate with an MLVA profile different (more than five summed tandem repeat differences)
from that of other isolates in the same specimen, thereby potentially obscuring epidemiological links between
C. difficile infection cases.
The incidence and severity of Clostridium difficile infection
(CDI) have increased in recent years, possibly due to the emer-
gence and spread of epidemic strain PCR ribotype 027 (also
known as pulsed-field electrophoresis type NAP1) (9, 10, 12).
Ribotype 027 is highly prevalent in the United Kingdom (2),
making PCR ribotyping alone insufficient for investigating po-
tential cases of cross infection or differentiating between epi-
demic outbreaks. Multilocus variable-number tandem-repeat
analysis (MLVA) is a more discriminatory typing technique for
C. difficile (11, 14) and has been used for several studies (1,
4–7), but as yet, no data on the subtyping of multiple isolates
from the same specimen have been published.
We investigated whether MLVA typing could identify dif-
ferent subtypes of ribotype 027 within the same specimen and
considered the impact this may have on the utility of MLVA as
a typing method for outbreak situations.
(This work was presented in part as poster 525 at the Euro-
pean Congress of Clinical Microbiology and Infectious Dis-
eases, 16 May 2009.)
Thirty-nine feces samples (preselected by infection control
teams on the basis of severity, clusters, or high CDI rates)
submitted for PCR ribotyping and yielding a type 027 C. diffi-
cile isolate were arbitrarily selected. C. difficile was cultured
from specimens using alcohol shock and inoculation onto cy-
closerine-cefoxitin-fructose agar. Five isolated colonies of C.
difficile were picked from each culture and were all confirmed
as C. difficile type 027 by PCR ribotyping (13), giving 195 study
isolates.
Six variable-number tandem-repeat (VNTR) loci (A6Cd,
B7Cd, C6Cd, E7Cd, G8Cd, and CDR60) from published
MLVA schemes (11, 14) were amplified by PCR from all
isolates. Loci F3Cd and H9Cd (14) were not used, as they are
invariant within PCR ribotype 027 isolates (6, 8, 14). Loci
CDR5 and CD59 (11) were not used, as they were found to be
variant by only one tandem repeat or invariant in diverse 027
isolates (data not shown). Primers were used as previously
described (14), except for the G8Cd reverse primer (5 AAT
CTAATAATCCAGTAATTTAAATT 3), which was rede-
signed to improve the yield of G8Cd, and CDR60 primers
(CDR60-Forward, 5-AGTTTGTAGGGAAGTGTGTAAAT
AGAT-3; CDR60-Reverse, 5-CGCATTAAATTTCACTCC
TCAT-3), which were redesigned to minimize the PCR prod-
uct size. Five-microliter volumes of DNA extracts were added
to 20 l of PCR mixture, giving (final concentrations) 0.2 M
each primer, 2.5 mM MgCl2, 0.2 mM each deoxynucleoside
triphosphate, 1 GeneAmp PCR Gold buffer, and 0.5 U of
AmpliTaq Gold DNA polymerase (Applied Biosystems). Re-
action mixtures underwent activation at 95°C for 5 min, fol-
lowed by 35 cycles of 95°C for 1 min, 56°C for 1 min, and 72°C
for 1 min with a final elongation at 72°C for 5 min. PCR
products were electrophoresed on 3% MetaPhor agarose
(Lonza) gels in 0.5 Tris-borate-EDTA buffer at 150 V for 5 h
against a 20-bp molecular size standard (Sigma-Aldrich Com-
pany Ltd.). Gels were stained with ethidium bromide and pho-
tographed under UV light. PCR product sizes were deter-
mined using BioNumerics software (Applied Maths) by
comparison with a standard curve generated from the 20-bp
ladder. VNTR numbers were calculated from PCR product
sizes. Tandem-repeat numbers from each VNTR locus were
concatenated for each isolate to form MLVA profiles, which
were compared using BioNumerics software (Applied Maths).
The accuracy of determining VNTR numbers using the aga-
rose gel method described was validated by sequencing 35 differ-
ent VNTR PCR products using an ABI 3700 capillary sequencer
to determine exact repeat numbers and then comparing them
with numbers determined by the agarose gel method. A range of
PCR product sizes from each locus including PCR products dif-
fering in size by one 6-bp repeat were included. The agarose gel
method was accurate for 28 of 35 sequenced products with an
error of plus or minus one repeat in the remaining seven. The
impact of any such error was minimized by ensuring that PCR
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products from the same locus for isolates from the same specimen
were electrophoresed in adjacent lanes of the gel, making the
smallest 6-bp differences clearly visible. Thus, any error was un-
likely to affect the calculated differences between isolates. Accu-
rate size determination methods such as sequencing would be
required for larger-scale comparisons.
Studies using C. difficile MLVA (1, 4, 5, 7) have utilized the
Manhattan coefficient to calculate a summed tandem-repeat
FIG. 1. MLVA profiles and minimum spanning trees for specimens yielding C. difficile PCR ribotype 027 isolates at least one of which had an STRD
of five or more from the next most closely related isolate. For minimum spanning trees, circles represent unique MLVA profiles in the tree and are scaled
by member count. Thick solid lines represent an STRD of one, thin solid lines represent an STRD of two, thick dashed lines represent an STRD of three,
and thinner dashed lines represent an STRD of four or more. STRDs of more than four are indicated by numerals between the circles. Gray shading
indicates complexes with a maximum neighbor distance of two tandem repeats and a minimum of two MLVA types.
TABLE 1. MLVA profiles of specimens containing C. difficile PCR ribotype 027 isolates differing from each other at three
out of six VNTR loci
Specimen and
isolate(s)
No. of repeats at VNTR locus: Isolates within specimen with categorical
differences at three lociA6Cd B7Cd C6Cd E7Cd G8Cd CDR60
1
a 39 18 45 10 15 10 a and b at loci A6Cd, B7Cd, and C6Cd
b 37 17 53 10 15 10
c, e 38 18 46 10 15 10
d 38 18 45 10 15 10
3
a 18 7 17 12 15 10 c and e at loci A6Cd, C6Cd, and G8Cd
b 41 8 17 12 15 10
c 40 7 17 12 16 10
d 42 7 17 12 15 10
e 31 7 18 12 15 10
28
a, e 38 22 22 12 15 10 a, e and b at loci A6Cd, B7Cd, and G8Cd
b 37 21 22 12 16 10
c 37 22 23 12 15 10
d 37 22 22 12 15 10
29
a, b 38 21 21 12 16 10 d and e at loci A6Cd, B7Cd, and C6Cd
c 38 20 21 12 16 10
d 38 20 20 12 16 10
e 39 21 21 12 16 10
35
a 34 20 20 12 17 10 a and c at loci A6Cd, B7Cd, and C6Cd
b 35 21 20 12 17 10
c 35 21 19 12 17 10
d, e 34 21 20 12 17 10
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difference (STRD) from all loci and associate MLVA types
with the smallest STRDs. It has been suggested that C. difficile
isolates with an STRD of two or fewer should be considered
“clonal” (1, 4, 7, 14). We applied this method to compare
MLVA profiles within each study specimen. Thirty-four spec-
imens (87%) were found to contain isolates which were indis-
tinguishable or had an STRD of no more than two from an-
other isolate from the same specimen. Five specimens (13%)
contained at least one isolate which had an STRD of five or
more from the next most closely related isolate (Fig. 1).
It is a disadvantage of the Manhattan coefficient that if several
repeats at a locus are deleted or duplicated simultaneously, the
resulting STRD is large and similarities are obscured.
For this reason, we made alternative comparisons of isolate
MLVA profiles within each specimen using the categorical
coefficient which associates MLVA types with the smallest
number of VNTR locus variants. This revealed that 5 (13%)
out of 39 specimens contained isolates differing from each
other at three out of six loci (Table 1). Two specimens (1 and
3) contain isolates that differ by both analyses.
The possibility of multistrain acquisition cannot be dis-
counted as an explanation for the variation within specimens
seen in this study. However, it was observed that the incidence
of tandem-repeat number difference between isolates from one
specimen was greater at some loci, being seen in A6Cd, C6Cd,
B7Cd, and G8Cd in 20, 16, 7, and 3 out of 39 specimens,
respectively, but never at loci E7Cd and CDR60. The stability
of some loci within specimens, while still observed to be vari-
able between specimens, suggests that rapid evolution of some
loci within the host is a plausible explanation for the intraspeci-
men variation seen.
This study reinforces observations that the current MLVA
schemes for C. difficile may be too discriminatory (3, 8). The
MLVA profile variations we observed in some specimens could
potentially obscure epidemiological links, depending on which
isolates are picked from the primary culture. If investigating
clusters of CDI, it may be necessary to MLVA type more than
one isolate from a specimen to ensure that true epidemiolog-
ical links are not missed.
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